TrademarkDir
RESILIA PHARMACEUTICALS
LIVE

Serial Number

90448104

Owner

Peak Pharma Commercial Partners, LLC

Attorney

Julie Beth Albert

First Use Date

May 3, 2023

Filing Date

Jan 5, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

RESILIA PHARMACEUTICALS Trademark

Serial Number: 90448104 • Registration: 7202460

RESILIA PHARMACEUTICALS is a trademark filed by Peak Pharma Commercial Partners, LLC on January 5, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Peak Pharma Commercial Partners, LLC (3 trademarks)

New York, NY 10017

Entity Type: 16

Trademark Details

Filing Date

January 5, 2021

Registration Date

October 24, 2023

First Use Anywhere

May 3, 2023

First Use in Commerce

May 3, 2023

Published for Opposition

December 7, 2021

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 24, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 24, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 19, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 16, 2023 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 22, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 22, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 1, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 30, 2023 AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 30, 2023 AITU
USE AMENDMENT FILED
May 8, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
May 8, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 31, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jan 27, 2023 EX2G
SOU EXTENSION 2 FILED
Jan 27, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 27, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 13, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jul 11, 2022 EX1G
SOU EXTENSION 1 FILED
Jul 11, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 11, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 1, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 2, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 22, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 22, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jul 22, 2021 CNRT
ASSIGNED TO EXAMINER
Jul 14, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2021 NWOS
NEW APPLICATION ENTERED
Jan 8, 2021 NWAP

Related Trademarks

More from this Owner

SANTEFIRM CONSUMER HEALTHCARE

SANTEFIRM CONSUMER HEALTHCARE

SANTEFIRM CONSUMER HEALTHCARE

SANTEFIRM CONSUMER HEALTHCARE

SANTEFIRM CONSUMER HEALTHCARE

SANTEFIRM CONSUMER HEALTHCARE

RESILIA PHARMACEUTICALS, INC. logo

RESILIA PHARMACEUTICALS, INC.

RESILIA PHARMACEUTICALS, INC. logo

RESILIA PHARMACEUTICALS, INC.

RESILIA PHARMACEUTICALS, INC. logo

RESILIA PHARMACEUTICALS, INC.